Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00390481 · ClinicalTrials.gov registry record · NA

Study of Carotid Occlusion and Neurocognition

A NA study of Carotid Artery Diseases, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
294
Enrollment target
1
Study location

NCT00390481 is a NA study of Carotid Artery Diseases that has completed, run by Columbia University. The registered enrollment target is 294 participants, below the 1,626-participant average among 6 other Carotid Artery Diseases trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00390481, a NA study of Carotid Artery Diseases, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
294 participants
Enrollment target
1
Study location

Study Summary

To determine the relationship between cognitive functioning and blood flow in the brain among patients randomized to either extracranial-intracranial (EC-IC) bypass or medical therapy alone in the Carotid Occlusion Surgery Study (COSS).

Conditions Studied

Interventions

  • PROCEDURE EC-IC Bypass in the COSS study

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 294 participants
Start Date 2004-11
Est. Completion 2012-06
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT00390481

The ClinicalTrials.gov registry entry for NCT00390481 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 294 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,626-participant average among 6 other Carotid Artery Diseases trials with a reported enrollment target (82% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Carotid Artery Diseases appearing as the primary indexed condition, and to 1 intervention - of which EC-IC Bypass in the COSS study is the first listed.

NCT00390481 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00390481 about?

NCT00390481 is a clinical study titled "Study of Carotid Occlusion and Neurocognition". To determine the relationship between cognitive functioning and blood flow in the brain among patients randomized to either extracranial-intracranial (EC-IC) bypass or medical therapy alone in the Carotid Occlusion Surgery Study (COSS).

What is the current status of trial NCT00390481?

This trial is currently completed. It is a NA study. The enrollment target is 294 participants. The study started on 2004-11. Estimated completion is 2012-06.

What conditions does trial NCT00390481 study?

This clinical trial studies the following conditions: Carotid Artery Diseases.

What interventions are being tested in trial NCT00390481?

The interventions under investigation include: EC-IC Bypass in the COSS study (PROCEDURE).

Who is sponsoring clinical trial NCT00390481?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00390481 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Carotid Artery Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.